SEC Form 4 · accession 0001437749-17-017447
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Lane Midyett
Officer — Chief Operations Officer
Period of report
Oct 19, 2017
Accepted (ET)
Oct 23, 2017 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 20, 2017 | M | 7,145 | $13.00 | A | 91,614 | D | |
| Common Stock | Oct 20, 2017 | F | 2,685 | $13.00 | D | 88,929 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $12.65 | Oct 19, 2017 | M | 15,000 | A | Nov 19, 2017 | Oct 19, 2024 | Common Stock | 15,000 | 75,000 | D |
| Right to Buy Restricted Stock Unit (RSU)F2,F1 | — | Oct 19, 2017 | M | 5,000 | A | — | Oct 19, 2020 | Common Stock | 5,000 | 5,000 | D |
| Right to Buy Restricted Stock Unit (RSU)F1 | $13.00 | Oct 20, 2017 | M | 7,145 | D | Oct 20, 2017 | Oct 20, 2017 | Common Stock | 7,145 | 7,145 | D |
Explanation of responses
- F1Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.
- F2The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.